Previous in vitro investigations have shown that melanoma cells have different sensitivity to TRAIL and TRAIL-armed oncolytic viruses ranging from high sensitivity to nearly complete resistance [24, 32, 33]. The gene discussed is TNFSF10; the disease is melanoma.